Gastrointestinal involvement in mantle cell lymphoma: A prospective clinic, endoscopic, and pathologic study

American Journal of Surgical Pathology

Volumn 30, Issue 10, 2006, Pages 1274-1280

  Salar, Antonio ^a   Juanpere, Nuria ^a   Bellosillo, Beatriz ^a   Domingo Domenech, Eva ^b   Espinet, Blanca ^a   Seoane, Agustín ^a   Romagosa, Vicente ^b   Gonzalez Barca, Eva ^b   Panades, Agustín ^a   Pedro, Carmen ^a   Nieto, Miguel ^a   Abella, Eugenia ^a   Solé, Francesc ^a   Ariza, Aurelio ^c   Fernández Sevilla, Alberto ^b   Besses, Carlos ^a   Serrano, Sergio ^a  

^a HOSPITAL DEL MAR   (Spain)

^b CATALAN INSTITUTE OF ONCOLOGY   (Spain)

^c HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL   (Spain)

Author keywords

Cyclin D1; Gastrointestinal; Immunohistochemistry; Mantle cell lymphoma; t(11; 14)

Indexed keywords

CD20 ANTIGEN; CD5 ANTIGEN; CYCLIN D1; IMMUNOGLOBULIN HEAVY CHAIN;

ADULT; AGED; ARTICLE; BIOPSY; CLINICAL ARTICLE; COLON; COLON MUCOSA; ENDOSCOPY; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GASTRITIS; GASTROINTESTINAL TRACT; GENE; HUMAN; HUMAN TISSUE; INTESTINE; LYMPHOCYTIC INFILTRATION; MALE; MANTLE CELL LYMPHOMA; POLYMERASE CHAIN REACTION; POLYP; STOMACH; STOMACH MUCOSA; UPPER GASTROINTESTINAL TRACT;

AGED; BONE MARROW CELLS; CLONE CELLS; CYCLIN D1; ENDOSCOPY, GASTROINTESTINAL; FEMALE; GASTRIC MUCOSA; GASTROINTESTINAL NEOPLASMS; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; INTESTINAL MUCOSA; LYMPHOMA, MANTLE-CELL; MALE; MIDDLE AGED; PROGNOSIS; PROSPECTIVE STUDIES; TUMOR MARKERS, BIOLOGICAL;

EID: 33749010318     PISSN: 01475185     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.pas.0000208899.15859.cb     Document Type: Article

References (47)

1. Argatoff LH, Connors JM, Klasa RJ, et al. Mantle cell lymphoma: a clinicopathologic study of 80 cases. Blood. 1997;89:2067-2078.
2. Banks PM, Chan J, Cleary ML, et al. Mantle cell lymphoma. A proposal for unification of morphologic, immunologic, and molecular data. Am J Surg Pathol. 1992;16:637-640.
3. Barranco C, Mate JL, Ariza A, et al. Catalyzed signal amplification for cyclin D1 detection in mantle cell lymphoma. Mod Pathol. 2003;16:161-165.
4. Belaud-Rotureau MA, Parrens M, Dubus P, et al. A comparative analysis of FISH, RT-PCR, PCR, and immunohistochemistry for the diagnosis of mantle cell lymphomas. Mod Pathol. 2002;15:517-525.
5. Bertini M, Rus C, Freilone R, et al. Mantle cell lymphoma: a retrospective study on 27 patients. Clinical features and natural history. Haematologica. 1998;83:312-316.
6. Bosch F, Lopez-Guillermo A, Campo E, et al. Mantle cell lymphoma: presenting features, response to therapy, and prognostic factors. Cancer. 1998;82:567-575.
7. Campo E. Genetic and molecular genetic studies in the diagnosis of B-cell lymphomas I: mantle cell lymphoma, follicular lymphoma, and Burkitt's lymphoma. Human Pathol. 2003;34:330-335.
8. Campo E, Raffeld M, Jaffe ES. Mantle-cell lymphoma. Semin Hematol. 1999;36:115-127.
9. Chim CS, Chan ACL, Choo CK, et al. Mantle cell lymphoma in the Chinese: clinicopathologic features and treatment outcome. Am J Hematol. 1998;49:295-301.
10. Chim CS, Shek TWH, Liang R. Malignant lymphomatous polyposis in MALT lymphoma of colon. J Clin Oncol. 2003;21:953-955.
11. Cornes JS. Multiple lymphomatous polyposis of the gastrointestinal tract. Cancer. 1961;142:49-57.
12. Cruveilhier J. Maladies de l'estomac et des intestines. In: Cruveilhier J, ed. Anatomic Pathologique du Corps Humain. Vol. 2, Sect. 34. Paris: JB Balliere; 1835-1842:1-6.
13. Decaudin D, Bosq J, Munck JN, et al. Mantle cell lymphomas: characteristics, natural history and prognostic factors of 45 cases. Leuk Lymphoma. 1997;26:539-550.
14. Fisher RI, Dahlberg S, Nathwani BN, et al. A clinical analysis of two indolent lymphoma entities: mantle cell lymphoma and marginal zone lymphoma (including the mucosa-associated lymphoid tissue and monocytoid B-cell subcategories): a Southwest Oncology Group study. Blood. 1995;85:1075-1082.
15. Harris NL, Jaffe ES, Stein H, et al. A Revised European-American Classification of Lymphoid Neoplasms: a proposal from the International Lymphoma Study Group. Blood. 1994;84:1361-1392.
16. Hiddemann W, Unterhalt M, Herrmann R, et al. Mantle-cell lymphomas have more widespread disease and a slower response to chemotherapy compared with follicle-center lymphomas: results of a prospective comparative analysis of the German Low-Grade Lymphoma Study Group. J Clin Oncol. 1998;16:1922-1930.
17. Isaacson P, MacLennan K, Subbuswamy S. Multiple lymphomatous polyposis of the gastrointestinal tract. Histopathology. 1984;8:641-656.
18. Jaffe ES, Harris NL, Stein H, et al, eds. Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues. WHO Classification of Tumours. Lyon: IARC Press; 2001.
19. Kodet R, Mrhalova M, Krskova L, et al. Mantle cell lymphoma: improved diagnostics using a combined approach of immunohistochemistry and identification of t(11;14)(q13;q32) by polymerase chain reaction and fluorescence in situ hybridization. Virchows Arch. 2003;442:538-547.
20. Lardelli P, Bookman MA, Sundeen J, et al. Lymphocytic lymphoma of intermediate differentiation. Morphologic and immunophenotypic spectrum and clinical correlations. Am J Surg Pathol. 1990;4:752-763.
21. Luthra R, Hai S, Pugh WC. Polymerase chain reaction detection of the t(11;14) translocation involving the bcl-1 major translocation cluster in mantle cell lymphoma. Diagn Mol Pathol. 1995;4:4-7.
22. Majlis A, Pugh W, Rodriguez MA, et al. Mantle cell lymphoma: correlation of clinical outcome and biologic features with three histologic variants. J Clin Oncol. 1997;15:1664-1671.
23. Medeiros LJ, van Krieken JH, Jaffe ES, et al. Association of bcl-1 rearrangements with lymphocytic lymphoma of intermediate differentiation. Blood. 1990;76:2086-2090.
24. Meusers P, Hense J, Brittinger G. Mantle cell lymphoma: diagnostic criteria, clinical aspects and therapeutic problems. Leukemia. 1997;11:S60-S64.
25. Norton AJ, Matthews J, Pappa V, et al. Mantle cell lymphoma: natural history defined in a serially biopsied population over a 20-year period. Ann Oncol. 1995;6:249-256.
26. O'Briain DS, Kennedy MJ, Daly PA, et al. Multiple lymphomatous polyposis of the gastrointestinal tract. A clinicopathologically distinctive form of non-Hodgkin's lymphoma of B-cell centrocytic type. Am J Surg Pathol. 1989;13:691-699.
27. Oinonen R, Franssila K, Teerenhovi L, et al. Mantle cell lymphoma: clinical features, treatment and prognosis of 94 patients. Eur J Cancer. 1998;34:329-336.
28. Pinyol M, Campo E, Nadal A, et al. Detection of the bcl-1 rearrangement at the major translocation cluster in frozen and paraffin-embedded tissues of mantle cell lymphomas by polymerase chain reaction. Am J Clin Pathol. 1996;105:532-537.
29. Pittaluga S, Wlodarska I, Stul MS, et al. Mantle cell lymphoma: a clinicopathological study of 55 cases. Histopathology. 1995;26:17-24.
30. Rimokh R, Berger F, Delsol G, et al. Detection of the chromosomal translocation t(11;14) by polymerase chain reaction in mantle cell lymphomas. Blood. 1994;83:1871-1875.
31. Romaguera JE, Khouri IF, Kantarjian HM, et al. Untreated aggressive mantle cell lymphoma: results with intensive chemotherapy without stem cell transplant in elderly patients. Leuk Lymphoma. 2000;39:77-85.
32. Romaguera JE, Medeiros LJ, Hagemeister FB, et al. Frequency of gastrointestinal involvement and its clinical significance in mantle cell lymphoma. Cancer. 2003;97:586-591.
33. Rosenwald A, Wright G, Wiestner A, et al. The proliferation gene expression signature is a quantitative integrator of oncogenic events that predicts survival in mantle cell lymphoma. Cancer Cell. 2003;3:185-197.
34. Ruskoné-Fourmestraux A, Delmer A, Lavergne A, et al. Multiple lymphomatous polyposis of the gastrointestinal tract: a prospective clinicopathologic study of 31 cases. Gastroenterology. 1997;112:7-18.
35. Salar A, Fernández de Sevilla A, Romagosa V, et al. Distribution and incidence rates of lymphoid neoplasms according to the REAL classification in a single institution. A prospective study of 940 cases. Eur J Haematol. 1997;59:231-237.
36. Samaha H, Dumontet C, Ketterer N, et al. Mantle cell lymphoma: a retrospective study of 121 cases. Leukemia. 1998;12:1281-1287.
37. Siebert R, Matthiesen P, Harder S, et al. Application of interphase cytogenetics for the detection of t(11;14)(q13;q32) in mantle cell lymphomas. Ann Oncol. 1998;9:519-526.
38. Teodorovic I, Pittaluga S, Kluin-Nelemans JC, et al. Efficacy of four different regimens in 64 mantle-cell lymphoma cases: clinicopathologic comparison with 498 other non-Hodgkin's lymphoma subtypes. European Organization for the Research and Treatment of Cancer Lymphoma Cooperative Group. J Clin Oncol. 1995;13:2819-2826.
39. The Non-Hodgkin's Lymphoma Classification Project. A clinical evaluation of the International Lymphoma Study Group classification of non-Hodgkin's lymphoma. Blood. 1997;89:3909-3918.
40. Tsujimoto Y, Jaffe E, Cossman J, et al. Clustering of breakpoints on chromosome 11 in human B-cell neoplasms with the t(11;14) chromosome translocation. Nature. 1985;315:340-343.
41. van Dongen JJ, Langerak AW, Bruggemann M, et al. Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: report of the BIOMED-2 concerted action BMH4-CT98-3936. Leukemia. 2003;17:2257-2317.
42. Vandenberghe E, Wolf-Peeters C, Vaughan HG, et al. The clinical outcome of 65 cases of mantle cell lymphoma initially treated with non-intensive therapy by the British National Lymphoma Investigation Group. Br J Haematol. 1997;99:842-847.
43. Velders GA, Kluin-Nelemans JC, De Boer CJ, et al. Mantle-cell lymphoma: a population-based clinical study. J Clin Oncol. 1996;14:1269-1274.
44. Weisenburger DD, Vose JM, Greiner TC, et al. Mantle cell lymphoma: a clinicopathologic study of 68 cases from the Nebraska Lymphoma Study Group. Am J Hematol. 2000;64:190-196.
45. Yatabe Y, Suzuki R, Tobinai K, et al. Significance of cyclin D1 overexpression for the diagnosis of mantle cell lymphoma: a clinicopathologic comparison of cyclin D-1 positive MCL and cyclin D1-negative MCL-like B-cell lymphoma. Blood. 2000;95:2253-2261.
46. Zucca E, Fontana S, Roggero E, et al. Treatment and prognosis of centrocytic (mantle cell) lymphoma: a retrospective analysis of twenty-six patients treated in one institution. Leuk Lymphoma. 1994;13:105-110.
47. Zucca E, Stein H, Coiffer B. European lymphoma task force (TLTF): report of the workshop on mantle cell lymphoma (MCL). Ann Oncol. 1994;5:507-511.